Literature DB >> 22482125

Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.

Wei Li1, Jonathan Cooper, Matthias A Karajannis, Filippo G Giancotti.   

Abstract

Inhibition of proliferation by cell-to-cell contact is essential for tissue organization, and its disruption contributes to tumorigenesis. The FERM domain protein Merlin, encoded by the NF2 tumour suppressor gene, is an important mediator of contact inhibition. Merlin was thought to inhibit mitogenic signalling and activate the Hippo pathway by interacting with diverse target-effectors at or near the plasma membrane. However, recent studies highlight that Merlin pleiotropically affects signalling by migrating into the nucleus and inducing a growth-suppressive programme of gene expression through its direct inhibition of the CRL4DCAF1 E3 ubiquitin ligase. In addition, Merlin promotes the establishment of epithelial adhesion and polarity by recruiting Par3 and aPKC to E-cadherin-dependent junctions, and by ensuring the assembly of tight junctions. These recent advances suggest that Merlin acts at the cell cortex and in the nucleus in a similar, albeit antithetic, manner to the oncogene β-catenin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22482125      PMCID: PMC3323126          DOI: 10.1038/embor.2012.11

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  128 in total

1.  Fluorescence resonance energy transfer analysis of merlin conformational changes.

Authors:  Robert F Hennigan; Lauren A Foster; Mary F Chaiken; Timmy Mani; Michelle M Gomes; Andrew B Herr; Wallace Ip
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

2.  Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.

Authors:  Hongchuan Jin; Tobias Sperka; Peter Herrlich; Helen Morrison
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

3.  Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas.

Authors:  R H Lekanne Deprez; P H Riegman; E van Drunen; U L Warringa; N A Groen; S Z Stefanko; J W Koper; C J Avezaat; P G Mulder; E C Zwarthoff
Journal:  J Neuropathol Exp Neurol       Date:  1995-03       Impact factor: 3.685

4.  The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.

Authors:  Sushmita Maitra; Rima M Kulikauskas; Heather Gavilan; Richard G Fehon
Journal:  Curr Biol       Date:  2006-04-04       Impact factor: 10.834

5.  Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.

Authors:  M Laulajainen; T Muranen; O Carpén; M Grönholm
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

6.  The Hippo tumor-suppressor pathway regulates apical-domain size in parallel to tissue growth.

Authors:  Fisun Hamaratoglu; Kathleen Gajewski; Leticia Sansores-Garcia; Clayton Morrison; Chunyao Tao; Georg Halder
Journal:  J Cell Sci       Date:  2009-06-16       Impact factor: 5.285

7.  Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling.

Authors:  Miguel A López-Lago; Tomoyo Okada; Miguel M Murillo; Nick Socci; Filippo G Giancotti
Journal:  Mol Cell Biol       Date:  2009-05-18       Impact factor: 4.272

8.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

Authors:  Nailing Zhang; Haibo Bai; Karen K David; Jixin Dong; Yonggang Zheng; Jing Cai; Marco Giovannini; Pentao Liu; Robert A Anders; Duojia Pan
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

9.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.

Authors:  S Tsukita; K Oishi; N Sato; J Sagara; A Kawai; S Tsukita
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling.

Authors:  N Funayama; F Fagotto; P McCrea; B M Gumbiner
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  62 in total

1.  Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.

Authors:  Ming Quan; Jiujie Cui; Tian Xia; Zhiliang Jia; Dacheng Xie; Daoyan Wei; Suyun Huang; Qian Huang; Shaojiang Zheng; Keping Xie
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

2.  Important recent insights into the genetics and biology of malignant pleural mesothelioma.

Authors:  Robert McMillan; Marjorie Zauderer; Matthew Bott; Marc Ladanyi
Journal:  Ann Cardiothorac Surg       Date:  2012-11

3.  Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Lu Zhou; Chenyi Yang; Hediye Erdjument-Bromage; David Zagzag; Matija Snuderl; Marc Ladanyi; C Oliver Hanemann; Pengbo Zhou; Matthias A Karajannis; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2014-07-14       Impact factor: 31.743

4.  Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression.

Authors:  Vinay Mandati; Laurence Del Maestro; Florent Dingli; Bérangère Lombard; Damarys Loew; Nicolas Molinie; Stephane Romero; Daniel Bouvard; Daniel Louvard; Alexis M Gautreau; Eric Pasmant; Dominique Lallemand
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

5.  Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.

Authors:  Irina M Shapiro; Vihren N Kolev; Christian M Vidal; Yuwaraj Kadariya; Jennifer E Ring; Quentin Wright; David T Weaver; Craig Menges; Mahesh Padval; Andrea I McClatchey; Qunli Xu; Joseph R Testa; Jonathan A Pachter
Journal:  Sci Transl Med       Date:  2014-05-21       Impact factor: 17.956

6.  The Hippo-YAP signaling pathway and contact inhibition of growth.

Authors:  Barry M Gumbiner; Nam-Gyun Kim
Journal:  J Cell Sci       Date:  2014-02-15       Impact factor: 5.285

7.  mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.

Authors:  Marco Giovannini; Nicolas-Xavier Bonne; Jeremie Vitte; Fabrice Chareyre; Karo Tanaka; Rocky Adams; Laurel M Fisher; Laurence Valeyrie-Allanore; Pierre Wolkenstein; Stephane Goutagny; Michel Kalamarides
Journal:  Neuro Oncol       Date:  2014-01-10       Impact factor: 12.300

Review 8.  Neurofibromatosis-related tumors: emerging biology and therapies.

Authors:  Matthias A Karajannis; Rosalie E Ferner
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

Review 9.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

10.  A novel alternative splicing isoform of NF2 identified in human Schwann cells.

Authors:  Fang Su; Zhengguang Zhou; Wen Su; Zishu Wang; Qiong Wu
Journal:  Oncol Lett       Date:  2016-06-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.